Catalyst Funds Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1K Sell
1,060
-2,840
-73% -$24.3K ﹤0.01% 642
2026
Q1
$21.4K Buy
+3,900
New +$43.1K ﹤0.01% 573
2025
Q3
– Sell
-1,317
Closed -$25.6K – 679
2025
Q2
$25.6K Buy
+1,317
New +$25.5K 0.01% 412

Other funds holding GUTS

Catalyst Funds Management's GUTS Position: Q2 2026 in Review

Catalyst Funds Management reduced its Fractyl Health (GUTS) stake by 73% in Q2 2026, selling an estimated $24.3K and leaving 1,060 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Catalyst Funds Management first reported a position in GUTS in Q2 2025 and has held it in 3 quarters since. The position peaked at $25.6K in Q2 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Catalyst Funds Management held 1,060 shares of Fractyl Health worth $10.1K as of Q2 2026.
  • Catalyst Funds Management sold 2,840 Fractyl Health shares in Q2 2026, an estimated $24.3K.
  • Fractyl Health made up ﹤0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #642 holding.
  • Catalyst Funds Management first reported a position in Fractyl Health in Q2 2025 and has held it in 3 quarters since.
  • Catalyst Funds Management's Fractyl Health position peaked at $25.6K in Q2 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.